.Pharmacolibrary.Drugs.ATC.J.J04AK03 .Pharmacolibrary.Drugs.ATC.J.J04AK03| name: | Terizidone |
| ATC code: | J04AK03 | route: | oral |
| n-compartments | 1 |
Terizidone is a derivative of cycloserine and is used as a second-line drug in the treatment of multidrug-resistant tuberculosis (MDR-TB). It is generally considered when conventional treatment is not effective or cannot be tolerated. Terizidone is not widely used today, with limited approval and its use often being restricted to specialized protocols.
No published pharmacokinetic (PK) studies directly report human PK parameters for terizidone. Estimates below are based on known properties of cycloserine, a structurally related compound, and general pharmacokinetic principles. The values are rough estimates and should not be used for clinical purposes.